Anlon Healthcare Board Approves Rs250 Crore Preferential Warrant Issue

Board approved proposal for up to Rs 250 Cr preferential issue of warrants convertible into equity shares to 2 promoters and 2 public investors for cash; price and number deferred. First cash equity raise since listing and large for its scale; comes while growth absorbs working capital with limits heavily drawn and major expansion pending. Price, warrant count, promoter-public split and use of proceeds not disclosed; 25% upfront with 75% on exercise within 18 months; stacks on pending non-cash subsidiary swap; needs shareholder nod.